All-In with Chamath, Jason, Sacks & Friedberg

Snapshot · All-In with Chamath, Jason, Sacks & Friedberg

All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

Explore episode Jun 12, 2026

Where this was said

EcoR1 Capital's Oleg Nodelman pitches Aktis Oncology

At 30:20 · chapter starts 27:19

Oleg Nodelman uses a military analogy to explain the history of cancer treatment before pitching Aktis Oncology — a radiopharmaceutical biotech with clinical data due in 2027 and Eli Lilly as a strategic backer.

Health & Fitness
Oleg Nodelman Explains Radiopharmaceuticals as Micro-Drone Warfare

All-In's Best Ideas Pitch Competition: 4 Investors Present … · Jun 12, 2026 Health & Fitness

Chemo is carpet bombing. Immunotherapy is recruiting local allies. Radiopharmaceuticals are micro drones: 2-centimeter precision, single-cell blast radius, autonomous targeting. Aktis Oncology has built the platform to deliver any radioactive payload to any target — and the data readout is less than a year away.

Similar snapshots